TH Open

LinksSchließen

Referenz

Sherwood MW, Douketis JD, Patel MR. , et al; ROCKET AF Investigators.
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).

Circulation 2014;
129 (18) 1850-1859

Bibliographische Angaben herunterladen

Aufrufen in: